Glucoset
Improving patient care by reducing the risk of death or complications associated with high or low blood sugar levels. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD41—61m (Dealroom.co estimates Jul 2023.)
Company register number 997780922
Trondheim Trøndelag (HQ)
Financials
Estimates*
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | - | <1m | <1m | <1m | - |
| % growth | 33 % | (86 %) | - | - | 751 % | 374 % | - |
| EBITDA | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) | - | - |
| % EBITDA margin | (13 %) | (731 %) | - | (16841 %) | (1054 %) | - | - |
| Profit | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) |
| % profit margin | (14 %) | (809 %) | - | (20565 %) | (1559 %) | (277 %) | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
€2.5m | Grant | ||
* | €3.4m | Grant | |
* | €6.0m | Series A | |
| Total Funding | AUD20.2m | ||
Related Content
Recent News about Glucoset
EditMore about Glucoset
EditDeveloper of a real-time intravascular blood glucose monitoring system designed to reduce harmful hypoglycemia. The company's system delivers continuous and accurate information on the patient's blood glucose level, enabling clinicians to make glucose control in ICUs possible and reduce mortality, complications, and costs.
Keywords: Healthcare Devices, Services, Supplies, Blood Glucose Level, Blood Glucose Meter, Glucose Control Equipment, Glucose Controlling Device, Glucose Leveling, Glucose Sensor, Monitor Glucose Level, Sensor Technology.
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.